SCEMBLIX

ASCIMINIB · Novartis Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

21 regulatory and trial events tracked for SCEMBLIX, covering 2021-10-29 to 2026-08-07. Get the full timeline:

Most recent: EMA Authorised: Scemblix (asciminib hydrochloride) — Novartis Europharm Limited